Akzo Nobel Is Very Much on Track: CEO

The transcript discusses the company's operating margin targets and market outlook for 2020, highlighting challenges due to market weaknesses and the impact of COVID-19, particularly in Wuhan. It addresses supply chain concerns in China and outlines the company's financial performance, strategy, and capital allocation plans, including a €500 million buyback and ongoing efforts to optimize operations and explore M&A opportunities.

What measures is the company taking to ensure the health and safety of its employees?

What sectors are expected to face delays in demand according to the company's assessment?

What is the company's strategy regarding capital allocation and returning cash to shareholders?